Literature DB >> 19275144

Path-integral method for predicting relative binding affinities of protein-ligand complexes.

Chandrika Mulakala1, Yiannis N Kaznessis.   

Abstract

We present a novel approach for computing biomolecular interaction binding affinities based on a simple path integral solution of the Fokker-Planck equation. Computing the free energy of protein-ligand interactions can expedite structure-based drug design. Traditionally, the problem is seen through the lens of statistical thermodynamics. The computations can become, however, prohibitively long for the change in the free energy upon binding to be determined accurately. In this work, we present a different approach based on a stochastic kinetic formalism. Inspired by Feynman's path integral formulation, we extend the theory to classical interacting systems. The ligand is modeled as a Brownian particle subjected to the effective nonbonding interaction potential of the receptor. This allows the calculation of the relative binding affinities of interacting biomolecules in water to be computed as a function of the ligand's diffusivity and the curvature of the potential surface in the vicinity of the binding minimum. The calculation is thus exceedingly rapid. In test cases, the correlation coefficient between actual and computed free energies is >0.93 for accurate data sets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275144      PMCID: PMC2671935          DOI: 10.1021/ja807460s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  40 in total

1.  Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases.

Authors:  Craig A Coburn; Shawn J Stachel; Yue-Ming Li; Diane M Rush; Thomas G Steele; Elizabeth Chen-Dodson; M Katharine Holloway; Min Xu; Qian Huang; Ming-Tain Lai; Jillian DiMuzio; Ming-Chih Crouthamel; Xiao-Ping Shi; Vinod Sardana; Zhongguo Chen; Sanjeev Munshi; Lawrence Kuo; Gergely M Makara; D Allen Annis; Praveen K Tadikonda; Huw M Nash; Joseph P Vacca; Tong Wang
Journal:  J Med Chem       Date:  2004-12-02       Impact factor: 7.446

2.  Free energies of ligand binding for structurally diverse compounds.

Authors:  Chris Oostenbrink; Wilfred F van Gunsteren
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

3.  Large-scale validation of a quantum mechanics based scoring function: predicting the binding affinity and the binding mode of a diverse set of protein-ligand complexes.

Authors:  Kaushik Raha; Kenneth M Merz
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

4.  Structural and thermodynamic studies of simple aldose reductase-inhibitor complexes.

Authors:  June M Brownlee; Erik Carlson; Amy C Milne; Erika Pape; David H T Harrison
Journal:  Bioorg Chem       Date:  2006-11-02       Impact factor: 5.275

Review 5.  A new class of models for computing receptor-ligand binding affinities.

Authors:  M K Gilson; J A Given; M S Head
Journal:  Chem Biol       Date:  1997-02

6.  A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.

Authors:  A Urzhumtsev; F Tête-Favier; A Mitschler; J Barbanton; P Barth; L Urzhumtseva; J F Biellmann; A Podjarny; D Moras
Journal:  Structure       Date:  1997-05-15       Impact factor: 5.006

7.  High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.

Authors:  Holger Steuber; Matthias Zentgraf; Alberto Podjarny; Andreas Heine; Gerhard Klebe
Journal:  J Mol Biol       Date:  2005-11-10       Impact factor: 5.469

8.  Structure-based design and synthesis of macroheterocyclic peptidomimetic inhibitors of the aspartic protease beta-site amyloid precursor protein cleaving enzyme (BACE).

Authors:  Stephen Hanessian; Gaoqiang Yang; Jean-Michel Rondeau; Ulf Neumann; Claudia Betschart; Marina Tintelnot-Blomley
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

9.  Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

Authors:  Michael C Van Zandt; Michael L Jones; David E Gunn; Leo S Geraci; J Howard Jones; Diane R Sawicki; Janet Sredy; Jorge L Jacot; A Thomas Dicioccio; Tatiana Petrova; Andre Mitschler; Alberto D Podjarny
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

10.  Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics.

Authors:  Stephen Hanessian; Hongying Yun; Yihua Hou; Gaoqiang Yang; Malken Bayrakdarian; Eric Therrien; Nicolas Moitessier; Silvio Roggo; Siem Veenstra; Marina Tintelnot-Blomley; Jean-Michel Rondeau; Christian Ostermeier; André Strauss; Paul Ramage; Paolo Paganetti; Ulf Neumann; Claudia Betschart
Journal:  J Med Chem       Date:  2005-08-11       Impact factor: 7.446

View more
  1 in total

1.  Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatin.

Authors:  Paola Magotti; Daniel Ricklin; Hongchang Qu; You-Qiang Wu; Yiannis N Kaznessis; John D Lambris
Journal:  J Mol Recognit       Date:  2009 Nov-Dec       Impact factor: 2.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.